Evidence map›Paper›PMID 21960744›Full record

ArticleInternational journal of medical sciences2011

A rare cause of bacteremia in a pediatric patient with Down syndrome: Sphingomonas paucimobilis.

Mehmet Özdemir, Sevgi Pekcan, Mehmet Emin Demircili, Fatma Esenkaya Taşbent, Bahadır Feyzioğlu, Şerife Pirinç, Mahmut Baykan

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of medical sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Gram-Negative Bacilli Isolated from Caves-International journal of environmental research and public health · 2022
    Review
  5. Evaluation ofIranian journal of microbiology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Sphingomonas paucimobilis infections in children: 24 case reports.Mediterranean journal of hematology and infectious diseases · 2013
    Article
  13. A Rare Case ofJournal of investigative medicine high impact case reports
    Article
  14. Otomastoiditis caused byAutopsy & case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mehmet ÖzdemirDepartment of Medical Microbiology, Selcuk University Meram Faculty of Medicine, Konya, Turkey. mehmetozdem@yahoo.com
Sevgi Pekcan
Mehmet Emin Demircili
Fatma Esenkaya Taşbent
Bahadır Feyzioğlu
Şerife Pirinç
Mahmut Baykan
Selçuk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingomonas paucimobilis, is a yellow-pigmented, aerobic, non fermentative, gram negative motile bacillus. S. paucimobilis which is widely found in nature and hospital environments rarely cause serious or life threatening infections. In this report, a case of hospital acquired bloodstream infection due to S. paucimobilis in a patient with Down syndrome who was on treatment for presumed pneumonia is presented. A one year-old child patient who was a known case of Down syndrome and had previously experienced cardiac surgery was hospitalized and treated for pneumonia. On the 12th day of hospitalization, blood cultures were taken because of a high body temperature. One of the blood cultures was positive for gram-negative rods. After 48 hour of incubation, the sub-cultures on blood agar medium yielded pure growth of a yellow, non-fermentative, gram-negative, rod-shaped bacterium. The microorganism was positive for oxidase, and esculin hydrolysis, while negative for urea and nitrate reduction, citrate utilisation and motility. The isolate had been identified as S. paucimobilis by using Vitek 2 system. The antibiotic susceptibility test was also performed with the same system and the strain was found to be susceptible to piperacillin-tazobactam and other antibiotics. Treatment with intravenous piperacilin-tazobactam (150 mg/kg/day) was initiated. He responded well to the treatment and was discharged after 10 days. This case is reported to emphasize that S. paucimobilis should be kept in mind as a nosocomial infectious agent in patients with Down syndrome and immunosuppressive patients and the infections should be treated according to the sensitivity test results.

Indexed as

BacteremiaCross InfectionDown SyndromeGram-Negative Bacterial InfectionsHumansInfantMalePenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationPneumoniaSphingomonasPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationbacteriemiaDown syndromehospitalinfectionSphingomonas paucimobilis

Identifiers

PMID21960744
PMCPMC3180768
OpenAlexW2155568430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.